查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771586

美国伤口凝胶市场规模、份额及趋势分析报告，按产品、抗菌特性、应用、最终用途、购买模式、分销管道、细分市场预测，2025-2033 年

U.S. Wound Gel Market Size, Share & Trends Analysis Report By Product (Dressings, Gels), By Antimicrobial Properties (Silver (Ag+), Non-Silver), By Application, By End-use, By Mode Of Purchase, By Distribution Channel, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国伤口凝胶市场规模与趋势：

预计 2024 年美国伤口凝胶市场规模为 21.1 亿美元，到 2033 年将达到 34.7 亿美元，2025 年至 2033 年的复合年增长率为 5.71%。

这一增长主要源于慢性伤口患病率的上升、对先进创伤护理解决方案的需求不断增长、老年人口的不断增长，以及用于加速伤口癒合的水凝胶配方的持续创新。此外，向门诊和居家照护的转变以及支持性报销政策也进一步推动了市场扩张。

根据美国人口普查局的数据，到2025年，人口中位数年龄预计将达到40岁，65岁及以上人口将达到约6000万，占总人口的18%。其中，80岁以上人口占4%。 2050年，老年人口预计将增加至8,000万，占65岁以上人口的25%，占80岁以上人口的8%。

美国军事和国防部门对伤口凝胶产品的需求不断增长，已成为市场的主要驱动力，这主要源于战斗和野外作业的独特高风险性质。军事人员经常遭受撕裂伤、烧烫伤和深度伤口等创伤，并且在传统外科手术难以获得的恶劣环境中，他们需要快速、高效且抗感染的治疗。在这些情况下，伤口凝胶提供了一种实用的解决方案；它们便于携带，易于涂抹，并提供保湿癒合环境，加速组织再生，同时最大限度地降低感染风险。

此外，美国国防部正在与生物技术公司合作开发先进的水凝胶配方，包括基于酵素和抗菌的伤口凝胶，专门用于战场。例如，美国于2024年11月决定与总部位于剑桥的生物技术公司SolasCure合作，在军事环境中评估该公司的伤口护理水凝胶Aurase伤口凝胶的效果。 Aurase伤口凝胶最初将采用源自蛆虫的重组酵素talmase。这种酵素在酵素脱屑方面非常有效，可以去除坏死组织并准备伤口床，从而为伤口管理提供一种受生物启发的解决方案，可支持自然癒合和替代疗法。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国伤口凝胶市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国伤口凝胶市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国伤口凝胶市场：产品评估与趋势分析

  • 细分仪表板
  • 美国伤口凝胶市场波动分析
  • 美国伤口凝胶市场规模与产品趋势分析（2021-2033）
  • 敷料
    • 水凝胶敷料
    • 凝胶纤维敷料
    • 其他的
  • 凝胶

第五章美国伤口凝胶市场：抗菌性能评估与趋势分析

  • 细分仪表板
  • 美国伤口凝胶市场波动分析
  • 2021-2033 年美国伤口凝胶市场规模及抗菌趋势分析
  • 银（Ag+）
  • 非银

第六章美国伤口凝胶市场：应用评估与趋势分析

  • 细分仪表板
  • 美国伤口凝胶市场波动分析
  • 美国伤口凝胶市场规模与应用趋势分析（2021-2033）
  • 慢性伤口
    • 糖尿病足溃疡（DFU）
    • 压疮
    • 腿部溃疡
  • 急性伤口
    • 手术切口
    • 烧烫伤
    • 撕裂伤、擦伤

第七章美国伤口凝胶市场：通路评估与趋势分析

  • 细分仪表板
  • 美国伤口凝胶市场波动分析
  • 2021 年至 2033 年美国伤口凝胶市场规模及通路趋势分析
  • 在线的
  • 离线

第八章美国伤口凝胶市场：购买模式评估与趋势分析

  • 细分仪表板
  • 美国伤口凝胶市场波动分析
  • 美国伤口凝胶市场规模及趋势分析（按购买方式），2021-2033 年
  • 处方笺
  • 无需处方笺

第九章美国伤口凝胶市场：最终用途估计和趋势分析

  • 细分仪表板
  • 美国伤口凝胶市场波动分析
  • 美国伤口凝胶市场规模及趋势分析（依最终用途），2021-2033 年
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 居家照护环境
  • 长期照护机构
  • 其他的

第十章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
  • Company Share Analysis, 2024
    • Medline Industries, LP.
    • Coloplast Corp
    • Molnlycke Health Care AB
    • Solventum
    • Convatec Inc.
    • Cresilon
    • Smith+Nephew
    • B. Braun SE
    • DermaRite Industries, LLC.
    • Integra LifeSciences Corporation
    • Sanara MedTech Inc.
Product Code: GVR-4-68040-621-3

U.S Wound Gel Market Size & Trends:

The U.S. wound gel market size was estimated at USD 2.11 billion in 2024 and is expected to grow at a CAGR of 5.71% from 2025 to 2033 to reach USD 3.47 billion by 2033. This growth is attributed to the rising prevalence of chronic wounds, increasing demand for advanced wound care solutions, a growing elderly population, and continuous innovations in hydrogel formulations that enhance healing outcomes. In addition, the shift toward outpatient and home-based care and supportive reimbursement policies is further accelerating market expansion.

According to data from the U.S. Census Bureau, by 2025, the population's average age is expected to reach 40 years, with approximately 60 million individuals aged 65 years or older accounting for 18% of the total population. Among them, 4% will be 80 years or older. By 2050, the number of elderly individuals is projected to rise to 80 million, representing 25% of the population aged 65 and above, while those aged 80 and over will comprise 8%.

The increasing demand for wound gel products from the U.S. military and defense sector is emerging as a significant market driver, primarily due to combat and field operations' unique and high-risk nature. Military personnel are frequently exposed to traumatic injuries, including lacerations, burns, and deep wounds, which require immediate, efficient, and infection-resistant treatment in austere environments where traditional surgical care is not readily available. In such scenarios, wound gels offer a practical solution-they are portable, easy to apply, and provide moisture-retentive healing environments that promote faster tissue regeneration while minimizing infection risks.

Furthermore, the U.S. Department of Defense has collaborated with biotechnology firms to develop advanced hydrogel formulations, including enzyme-based or antimicrobial wound gels designed specifically for battlefield use. For instance, in November 2024, the U.S. Army partnered with SolasCure, a Cambridge-based biotechnology company, to evaluate the company's investigational wound care hydrogel, Aurase Wound Gel, in military settings. Aurase wound gel features a recombinant enzyme, tarumase, derived initially from maggots. This enzyme is highly effective in enzymatic debridement, removing dead tissue and preparing the wound bed, offering a biologically inspired solution for wound management that supports natural and alternative healing approaches.

U.S. Wound Gel Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound gel market report based on product, antimicrobial properties, application, distribution channel, mode of purchase, and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Dressings
    • Hydrogel dressing
    • Gelling fiber dressings
    • Others
  • Gels
  • Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)
  • Silver (Ag+)
  • Non-Silver
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Chronic Wounds
    • Diabetic Foot Ulcers (DFUs)
    • Pressure Ulcers
    • Stage 1
    • Stage 2
    • Stage 3
    • Stage 4
    • Leg Ulcers
  • Acute Wounds
    • Surgical Incisions
    • Burns
    • 1st Degree
    • 2nd Degree
    • 3rd Degree
    • Lacerations, Abrasions
  • Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
  • Prescription
  • Non-prescription
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Offline
  • Online
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Homecare Settings
  • Long-Term Care Facilities
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Antimicrobial Properties
    • 1.2.3. Application
    • 1.2.4. Distribution Channel
    • 1.2.5. Mode of Purchase
    • 1.2.6. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Wound Gel Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Shift towards home healthcare
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising Prevalence of Chronic Diseases
      • 3.2.1.4. Rising aging population in the U.S.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory environment
      • 3.2.2.2. Limited reimbursement policies
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Increasing demand for wound gel products from the military and defense sector
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Rising competition among industry participants
  • 3.3. U.S. Wound Gel Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Gel Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Wound Gel Market Movement Analysis
  • 4.3. U.S. Wound Gel Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
  • 4.4. Dressings
    • 4.4.1. Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Hydrogel Dressing
      • 4.4.2.1. Hydrogel Dressing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Gelling Fiber Dressings
      • 4.4.3.1. Gelling Fiber Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Gels
    • 4.5.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Wound Gel Market Movement Analysis
  • 5.3. U.S. Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
  • 5.4. Silver (Ag+)
    • 5.4.1. Silver (Ag+) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-Silver
    • 5.5.1. Non-Silver Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Wound Gel Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Wound Gel Market Movement Analysis
  • 6.3. U.S. Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Chronic Wounds
    • 6.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Diabetic Foot Ulcers (DFUs)
      • 6.4.2.1. Diabetic Foot Ulcers (DFUs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Pressure Ulcers
      • 6.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.2. Stage 1
        • 6.4.3.2.1. Stage 1 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.3. Stage 2
        • 6.4.3.3.1. Stage 2 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.4. Stage 3
        • 6.4.3.4.1. Stage 3 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.5. Stage 4
        • 6.4.3.5.1. Stage 4 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Leg Ulcers
      • 6.4.4.1. Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Acute Wounds
    • 6.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Surgical Incisions
      • 6.5.2.1. Surgical Incisions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Burns
      • 6.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.2. 1st Degree
        • 6.5.3.2.1. 1st Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.3. 2nd Degree
        • 6.5.3.3.1. 2nd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.4. 3rd Degree
        • 6.5.3.4.1. 3rd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. Lacerations, Abrasions
      • 6.5.4.1. Lacerations, Abrasions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Wound Gel Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Wound Gel Market Movement Analysis
  • 7.3. U.S. Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 7.4. Online
    • 7.4.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Offline
    • 7.5.1. Offline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Wound Gel Market Movement Analysis
  • 8.3. U.S. Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
  • 8.4. Prescription
    • 8.4.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Non-prescription
    • 8.5.1. Non-prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. U.S. Wound Gel Market: End Use Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. U.S. Wound Gel Market Movement Analysis
  • 9.3. U.S. Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 9.4. Hospitals
    • 9.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Specialty Clinics
    • 9.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Ambulatory Surgery Center
    • 9.6.1. Ambulatory Surgery Center Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. Homecare Settings
    • 9.7.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8. Long-Term Care Facilities
    • 9.8.1. Long-Term Care Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.9. Others
    • 9.9.1. Long-term Care (residential living setting) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Key Company Profiles
  • 10.3. Company Share Analysis, 2024
    • 10.3.1. Medline Industries, LP.
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Product Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. Coloplast Corp
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Product Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Molnlycke Health Care AB
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Product Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. Solventum
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Product Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. Convatec Inc.
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Product Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. Cresilon
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Product Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. Smith+Nephew
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Product Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. B. Braun SE
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Product Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. DermaRite Industries, LLC.
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Product Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Integra LifeSciences Corporation
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Product Benchmarking
      • 10.3.10.4. Strategic Initiatives
    • 10.3.11. Sanara MedTech Inc.
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3. Product Benchmarking
      • 10.3.11.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. U.S. Wound Gel Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. U.S. Wound Gel Market, by Antimicrobial Properties, 2021 - 2033 (USD Million)
  • Table 5. U.S. Wound Gel Market, by Application, 2021 - 2033 (USD Million)
  • Table 6. U.S. Wound Gel Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7. U.S. Wound Gel Market, by Mode of Purchase, 2021 - 2033 (USD Million)
  • Table 8. U.S. Wound Gel Market, by End Use, 2021 - 2033 (USD Million)
  • Table 9. Participant's Overview
  • Table 10. Financial Performance
  • Table 11. Product Benchmarking
  • Table 12. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Wound Gel Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Wound Gel Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Wound Gel Market, for Dressings, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Wound Gel Market, for Hydrogel Dressing, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Wound Gel Market, for Gelling Fiber Dressings, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Wound Gel Market, for Gels, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Wound Gel Market, for Antimicrobial Properties, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Wound Gel Market, for Silver (Ag+), 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Wound Gel Market, for Non-Silver, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Wound Gel Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Wound Gel Market, for Chronic Wounds, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Wound Gel Market, for Diabetic Foot Ulcers (DFUs), 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Wound Gel Market, for Pressure Ulcers, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Wound Gel Market, for Stage 1, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Wound Gel Market, for Stage 2, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Wound Gel Market, for Stage 3, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Wound Gel Market, for Stage 4, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Wound Gel Market, for Leg Ulcers, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Wound Gel Market, for Acute Wound, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Wound Gel Market, for Surgical Incisions, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Wound Gel Market, for Burns, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Wound Gel Market, for 1st Degree, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Wound Gel Market, for 2nd Degree, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Wound Gel Market, for 3rd Degree, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Wound Gel Market, for Lacerations, Abrasions, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Wound Gel Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Wound Gel Market, for Hospitals, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Wound Gel Market, for Specialty Clinics, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Wound Gel Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. Wound Gel Market, for Homecare Settings, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. Wound Gel Market, for Long-Term Care Facilities, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. Wound Gel Market, for Distribution Channel, 2021 - 2033 (USD Million)
  • Fig. 47 U.S. Wound Gel Market, for Offline, 2021 - 2033 (USD Million)
  • Fig. 48 U.S. Wound Gel Market, for Online, 2021 - 2033 (USD Million)
  • Fig. 49 U.S. Wound Gel Market, for Mode of Purchase, 2021 - 2033 (USD Million)
  • Fig. 50 U.S. Wound Gel Market, for Prescription, 2021 - 2033 (USD Million)
  • Fig. 51 U.S. Wound Gel Market, for Non-prescription, 2021